vs
Side-by-side financial comparison of LivaNova PLC (LIVN) and Bristow Group Inc. (VTOL). Click either name above to swap in a different company.
Bristow Group Inc. is the larger business by last-quarter revenue ($377.3M vs $360.9M, roughly 1.0× LivaNova PLC). LivaNova PLC runs the higher net margin — 8.6% vs 4.9%, a 3.7% gap on every dollar of revenue. On growth, LivaNova PLC posted the faster year-over-year revenue change (12.1% vs 6.7%). LivaNova PLC produced more free cash flow last quarter ($50.2M vs $47.8M). Over the past eight quarters, LivaNova PLC's revenue compounded faster (10.6% CAGR vs 5.8%).
LivaNova, plc is an American medical device manufacturer based in the UK. The company develops devices used for cardiac surgery and neuromodulation. The company was formed in 2015 by a $2.7B merger between Houston, Texas-based Cyberonics, Inc. and Milan, Italy-based Sorin S.p.a. The company trades on the NASDAQ stock exchange under the ticker symbol "LIVN".
Bristow Helicopters Limited is a British civil helicopter operator originally based at Aberdeen Airport, Scotland, which is currently a part of the U.S.-based Bristow Group which in turn has its corporate headquarters in Houston, Texas, U.S. In 2020, Bristow Group was merged with Era Helicopters, a large U.S.-based commercial helicopter operator that was previously a division of Era Aviation, with the two companies then continuing to use the Bristow name.
LIVN vs VTOL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $360.9M | $377.3M |
| Net Profit | $30.9M | $18.4M |
| Gross Margin | 65.2% | — |
| Operating Margin | 11.8% | 8.5% |
| Net Margin | 8.6% | 4.9% |
| Revenue YoY | 12.1% | 6.7% |
| Net Profit YoY | -44.7% | -42.1% |
| EPS (diluted) | $0.57 | $0.61 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $360.9M | $377.3M | ||
| Q3 25 | $357.8M | $386.3M | ||
| Q2 25 | $352.5M | $376.4M | ||
| Q1 25 | $316.9M | $350.5M | ||
| Q4 24 | $321.8M | $353.5M | ||
| Q3 24 | $318.1M | $365.1M | ||
| Q2 24 | $318.6M | $359.7M | ||
| Q1 24 | $294.9M | $337.1M |
| Q4 25 | $30.9M | $18.4M | ||
| Q3 25 | $26.8M | $51.5M | ||
| Q2 25 | $27.2M | $31.7M | ||
| Q1 25 | $-327.3M | $27.4M | ||
| Q4 24 | $55.9M | $31.8M | ||
| Q3 24 | $33.0M | $28.2M | ||
| Q2 24 | $16.3M | $28.2M | ||
| Q1 24 | $-41.9M | $6.6M |
| Q4 25 | 65.2% | — | ||
| Q3 25 | 68.4% | — | ||
| Q2 25 | 67.8% | — | ||
| Q1 25 | 69.7% | — | ||
| Q4 24 | 68.2% | — | ||
| Q3 24 | 70.8% | — | ||
| Q2 24 | 68.7% | — | ||
| Q1 24 | 70.3% | — |
| Q4 25 | 11.8% | 8.5% | ||
| Q3 25 | 15.1% | 13.1% | ||
| Q2 25 | 15.4% | 11.3% | ||
| Q1 25 | 15.3% | 9.6% | ||
| Q4 24 | 11.5% | 9.0% | ||
| Q3 24 | 11.2% | 9.1% | ||
| Q2 24 | 12.6% | 12.4% | ||
| Q1 24 | 5.5% | 6.8% |
| Q4 25 | 8.6% | 4.9% | ||
| Q3 25 | 7.5% | 13.3% | ||
| Q2 25 | 7.7% | 8.4% | ||
| Q1 25 | -103.3% | 7.8% | ||
| Q4 24 | 17.4% | 9.0% | ||
| Q3 24 | 10.4% | 7.7% | ||
| Q2 24 | 5.1% | 7.8% | ||
| Q1 24 | -14.2% | 2.0% |
| Q4 25 | $0.57 | $0.61 | ||
| Q3 25 | $0.49 | $1.72 | ||
| Q2 25 | $0.50 | $1.07 | ||
| Q1 25 | $-6.01 | $0.92 | ||
| Q4 24 | $1.04 | $1.07 | ||
| Q3 24 | $0.60 | $0.95 | ||
| Q2 24 | $0.30 | $0.96 | ||
| Q1 24 | $-0.78 | $0.23 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $635.6M | $286.2M |
| Total DebtLower is stronger | $376.1M | $671.5M |
| Stockholders' EquityBook value | $1.2B | $1.1B |
| Total Assets | $2.6B | $2.3B |
| Debt / EquityLower = less leverage | 0.31× | 0.63× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $635.6M | $286.2M | ||
| Q3 25 | $646.1M | $245.5M | ||
| Q2 25 | $593.6M | $251.8M | ||
| Q1 25 | $738.4M | $191.1M | ||
| Q4 24 | $428.9M | $247.5M | ||
| Q3 24 | $346.4M | $200.3M | ||
| Q2 24 | $329.2M | $178.6M | ||
| Q1 24 | $309.2M | $140.6M |
| Q4 25 | $376.1M | $671.5M | ||
| Q3 25 | $434.5M | $675.0M | ||
| Q2 25 | $430.6M | $705.2M | ||
| Q1 25 | $628.2M | $701.9M | ||
| Q4 24 | $627.0M | $689.8M | ||
| Q3 24 | $625.5M | $629.1M | ||
| Q2 24 | $624.5M | $594.2M | ||
| Q1 24 | $623.8M | $544.1M |
| Q4 25 | $1.2B | $1.1B | ||
| Q3 25 | $1.2B | $1.0B | ||
| Q2 25 | $1.1B | $984.4M | ||
| Q1 25 | $1.0B | $931.7M | ||
| Q4 24 | $1.3B | $891.7M | ||
| Q3 24 | $1.3B | $899.2M | ||
| Q2 24 | $1.2B | $849.1M | ||
| Q1 24 | $1.2B | $820.7M |
| Q4 25 | $2.6B | $2.3B | ||
| Q3 25 | $2.6B | $2.3B | ||
| Q2 25 | $2.5B | $2.3B | ||
| Q1 25 | $2.6B | $2.2B | ||
| Q4 24 | $2.5B | $2.1B | ||
| Q3 24 | $2.5B | $2.1B | ||
| Q2 24 | $2.5B | $2.0B | ||
| Q1 24 | $2.5B | $1.9B |
| Q4 25 | 0.31× | 0.63× | ||
| Q3 25 | 0.38× | 0.65× | ||
| Q2 25 | 0.38× | 0.72× | ||
| Q1 25 | 0.61× | 0.75× | ||
| Q4 24 | 0.47× | 0.77× | ||
| Q3 24 | 0.48× | 0.70× | ||
| Q2 24 | 0.50× | 0.70× | ||
| Q1 24 | 0.51× | 0.66× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $82.4M | $76.9M |
| Free Cash FlowOCF − Capex | $50.2M | $47.8M |
| FCF MarginFCF / Revenue | 13.9% | 12.7% |
| Capex IntensityCapex / Revenue | 8.9% | 7.7% |
| Cash ConversionOCF / Net Profit | 2.67× | 4.17× |
| TTM Free Cash FlowTrailing 4 quarters | $173.3M | $56.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $82.4M | $76.9M | ||
| Q3 25 | $85.1M | $23.1M | ||
| Q2 25 | $62.9M | $99.0M | ||
| Q1 25 | $24.0M | $-603.0K | ||
| Q4 24 | $78.7M | $51.1M | ||
| Q3 24 | $51.0M | $66.0M | ||
| Q2 24 | $43.4M | $33.7M | ||
| Q1 24 | $10.0M | $26.7M |
| Q4 25 | $50.2M | $47.8M | ||
| Q3 25 | $62.2M | $-6.2M | ||
| Q2 25 | $47.8M | $67.4M | ||
| Q1 25 | $13.2M | $-52.7M | ||
| Q4 24 | $68.3M | $-32.4M | ||
| Q3 24 | $32.8M | $9.0M | ||
| Q2 24 | $31.2M | $-16.7M | ||
| Q1 24 | $3.6M | $-37.9M |
| Q4 25 | 13.9% | 12.7% | ||
| Q3 25 | 17.4% | -1.6% | ||
| Q2 25 | 13.6% | 17.9% | ||
| Q1 25 | 4.2% | -15.0% | ||
| Q4 24 | 21.2% | -9.2% | ||
| Q3 24 | 10.3% | 2.5% | ||
| Q2 24 | 9.8% | -4.6% | ||
| Q1 24 | 1.2% | -11.2% |
| Q4 25 | 8.9% | 7.7% | ||
| Q3 25 | 6.4% | 7.6% | ||
| Q2 25 | 4.3% | 8.4% | ||
| Q1 25 | 3.4% | 14.9% | ||
| Q4 24 | 3.2% | 23.6% | ||
| Q3 24 | 5.7% | 15.6% | ||
| Q2 24 | 3.8% | 14.0% | ||
| Q1 24 | 2.2% | 19.2% |
| Q4 25 | 2.67× | 4.17× | ||
| Q3 25 | 3.18× | 0.45× | ||
| Q2 25 | 2.32× | 3.12× | ||
| Q1 25 | — | -0.02× | ||
| Q4 24 | 1.41× | 1.61× | ||
| Q3 24 | 1.55× | 2.34× | ||
| Q2 24 | 2.65× | 1.20× | ||
| Q1 24 | — | 4.04× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LIVN
| Other | $169.4M | 47% |
| Neuromodulation Segment | $119.7M | 33% |
| Cardiopulmonary Segment | $71.8M | 20% |
VTOL
| Offshore Energy Services | $247.5M | 66% |
| Government Services | $100.1M | 27% |
| Other | $21.9M | 6% |
| Related Party | $7.8M | 2% |
